Standout Papers

Long-term safety of lamivudine treatment in patients with chronic hepatitis B 2003 2026 2010 2018 584
  1. Long-term safety of lamivudine treatment in patients with chronic hepatitis B (2003)
    Anna S. Lok, Ching‐Lung Lai et al. Gastroenterology

Immediate Impact

3 by Nobel laureates 89 standout
Sub-graph 1 of 20

Citing Papers

EASL Clinical Practice Guidelines on hepatitis delta virus
2023 Standout
Practical thematic analysis: a guide for multidisciplinary health services research teams engaging in qualitative analysis
2023 Standout
17 intermediate papers

Works of Nancy Little being referenced

Co-Development of a Web Application (COVID-19 Social Site) for Long-Term Care Workers (“Something for Us”): User-Centered Design and Participatory Research Study
2022
Lamivudine therapy in chronic delta hepatitis: a multicentre randomized‐controlled pilot study
2005

Author Peers

Author Last Decade Papers Cites
Nancy Little 1023 59 963 142 24 1.1k
Amy Jewett 941 47 900 144 19 1.3k
Geoff A. Beckett 988 54 1000 255 13 1.3k
Yousra A. Mohamoud 615 70 629 103 15 919
Nick Walsh 714 61 526 256 40 916
Maryam Alavi 973 63 943 150 64 1.1k
Stanley Wong 650 30 576 164 57 873
Troy A. Shahoumian 808 26 858 186 24 1.0k
Heather Valerio 892 43 832 109 52 988
Margaret MacDonald 808 102 412 239 31 1.0k
Jennifer H MacLachlan 760 38 543 204 41 935

All Works

Loading papers...

Rankless by CCL
2026